Order Code CYPAN Cytokine Panel, Plasma
Additional Codes
EPIC LAB1872ia
Specimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube: Lavender-top (EDTA)
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Immediately after specimen collection, place the tube on wet ice.
2. Centrifuge at 4° C, 1500 x g for 10 minutes.
3. Aliquot plasma into plastic vial.
4. Freeze specimen within 2 hours of collection.
Secondary ID
610259Useful For
Understanding the etiology of infectious or chronic inflammatory diseases, when used in conjunction with clinical information and other laboratory testing
Research studies in which an assessment of cytokine responses is needed
Method Name
Bead-Based Multiplex Immunoassay
Reporting Name
Cytokine Panel, PSpecimen Type
Plasma EDTASpecimen Minimum Volume
0.3 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Plasma EDTA | Frozen | 21 days |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | Reject |
Gross icterus | Reject |
Heat-treated specimen | Reject |
Clinical Information
Cytokines are important mediators of cell-to-cell communication within the innate and adaptive immune systems. The expression of most cytokines is highly regulated and generally occurs in response to foreign or self-antigenic stimulation. The functions of cytokines are extremely varied, with many cytokines also displaying pleiotropic effects, depending on their cellular target. Some cytokines, such as tumor necrosis factor (TNF), interleukin (IL)-1 beta, IL-6, interferon (IFN)-alpha and beta, IL-10, and IL-18 are particularly important in the innate immune response. For example, TNF, IL-1 beta, and IL-6 induce expression of acute phase proteins in the liver. TNF and IL-1 beta also lead to endothelial activation and are critical regulators of the hypothalamus, which can result in elevated body temperature. IL-6, in comparison, is a bridge to the adaptive immune response, by acting on B cells to induce proliferation. In contrast, IFN-alpha and IFN-beta (members of the type I IFN family) are key components of the innate immune response to viral infections. IFN-gamma, which is a type II IFN, has roles in both the innate and adaptive immune responses, including macrophage activation, induction of B-cell isotype switching, and T helper type 1 cell differentiation. Other cytokines, such as monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 alpha, are categorized as chemokines because they function primarily to attract leukocytes to the site of inflammation. Further, some cytokines act on hematopoietic stem cells to induce differentiation of various leukocytes. For example, granulocyte-monocyte colony stimulating factor induces myeloid progenitor cells to differentiate into neutrophils and monocytes. Lastly, for some cytokines, soluble forms of the receptor can be found in the peripheral circulation. The IL-2 soluble receptor is produced from proteolytic cleavage of the membrane-bound receptor, which occurs during T-cell activation. As a group, cytokines and their receptors represent a highly complex and critical regulator of a normal immune response.
Reference Values
Tumor necrosis factor: <10.0 pg/mL
Interleukin (IL)-6: <5.0 pg/mL
Interferon (IFN)-beta: <20.0 pg/mL
IL-10: <7.0 pg/mL
Monocyte chemoattractant protein-1: ≤198 pg/mL
IL-1 beta: <20.0 pg/mL
IFN-gamma: <60.0 pg/mL
Macrophage inflammatory protein-1 alpha: <220 pg/mL
Granulocyte-monocyte colony stimulating factor: <15.0 pg/mL
IL-2 receptor alpha soluble: ≤959 pg/mL
IFN-alpha: <20.0 pg/mL
IL-18: ≤468 pg/mL
Clinical Reference
1. Bozza FA, Salluh JI, Japiassu AM, et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care. 2007;11(2):R49. doi:10.1186/cc5783
2. Milman N, Karsh J, Booth RA. Correlation of a multi-cytokine panel with clinical disease activity in patients with rheumatoid arthritis. Clin Biochem. 2010;43(16-17):1309-1314. doi:10.1016/j.clinbiochem.2010.07.012
3. Teijara JR. Type I interferons in viral control and immune regulation. Curr Opin Virol. 2016;16:31-40. doi:10.1016/j.coviro.2016.01.001
4. Tisoncki JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. 2010;76(1):16-32. doi:10.1128/MMBR.05015-11
5. Garcia Borrega J, Godel P, Ruger MA, et al. In the eye of the storm: Immune-mediated toxicities associated with CAR-T cell therapy. Hemasphere. 2019;3(2):e191. doi:10.1097/HS9.0000000000000191
Day(s) Performed
Wednesday
Report Available
2 to 8 daysPerforming Laboratory
![](http://d3b6ik53zt4tlx.cloudfront.net/assets/performed-by-mcl.gif)
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
83520 x 10
83529
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
CYPAN | Cytokine Panel, P | 82335-1 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
610307 | TNF | 3074-2 |
610308 | IL-6 | 26881-3 |
610309 | IFN-beta | 97051-7 |
610310 | IL-10 | 26848-2 |
610311 | MCP-1 | 97052-5 |
610312 | IL-1 beta | 13629-1 |
610313 | IFN-gamma | 27415-9 |
610314 | MIP-1 alpha | 97053-3 |
610315 | GM-CSF | 97054-1 |
610316 | IL-2 receptor alpha soluble | 76039-7 |
610317 | IFN-alpha | 33820-2 |
610318 | IL-18 | 33823-6 |